[Immunosuppressive long term therapy of visceral lupus erythematosus].
D000328:Adult; D000577:Amides / Q000008:administration & dosage; D000974:Antibodies, Antinuclear / Q000097:blood; D001379:Azathioprine / Q000008:administration & dosage*; D003609:Dactinomycin / Q000008:administration & dosage; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage*; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009504:Neutrophils; D011241:Prednisone / Q000008:administration & dosage*; D014050:Toluene / Q000008:administration & dosage
D000577:Amides; D000974:Antibodies, Antinuclear; D006834:Hydrazines; D007166:Immunosuppressive Agents; D003609:Dactinomycin; D014050:Toluene; D015122:Mercaptopurine; D001379:Azathioprine; D011241:Prednisone; D008727:Methotrexate
Immunsuppressive Langzeittherapie des Lupus erythematodes visceralis.